Evangelos Sepsas

934 total citations
18 papers, 671 citations indexed

About

Evangelos Sepsas is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Evangelos Sepsas has authored 18 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 6 papers in Oncology. Recurrent topics in Evangelos Sepsas's work include Lung Cancer Diagnosis and Treatment (9 papers), Pleural and Pulmonary Diseases (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Evangelos Sepsas is often cited by papers focused on Lung Cancer Diagnosis and Treatment (9 papers), Pleural and Pulmonary Diseases (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Evangelos Sepsas collaborates with scholars based in Greece, United Kingdom and Kuwait. Evangelos Sepsas's co-authors include Panagiotis Misthos, Kalliopi Athanassiadi, Ioannis Skottis, Stamatis Kakaris, Marios Konstantinou, Stylianos Katsaragakis, Dimitrios Theodorou, John Kokotsakis, Katerina Goudevenou and Ioannis Vamvakaris and has published in prestigious journals such as The Journal of Experimental Medicine, Cancer and International Journal of Cancer.

In The Last Decade

Evangelos Sepsas

18 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evangelos Sepsas Greece 12 410 226 155 83 70 18 671
Shih‐Ching Kang Taiwan 14 110 0.3× 272 1.2× 66 0.4× 31 0.4× 96 1.4× 29 483
Weiguang Qiao China 11 125 0.3× 137 0.6× 105 0.7× 31 0.4× 10 0.1× 31 387
Byung Hee Kang South Korea 13 140 0.3× 185 0.8× 68 0.4× 24 0.3× 56 0.8× 51 576
Atsushi Imagawa Japan 15 910 2.2× 835 3.7× 119 0.8× 33 0.4× 11 0.2× 56 1.4k
Francesc Xavier Avilés‐Jurado Spain 12 167 0.4× 115 0.5× 76 0.5× 17 0.2× 13 0.2× 39 405
Serhan Tanju Türkiye 13 183 0.4× 181 0.8× 79 0.5× 8 0.1× 14 0.2× 61 485
Stewart R. Craig United Kingdom 13 395 1.0× 234 1.0× 166 1.1× 9 0.1× 7 0.1× 27 674
Louis Kozloff United States 13 324 0.8× 343 1.5× 26 0.2× 11 0.1× 118 1.7× 22 650
Genglong Liu China 13 66 0.2× 55 0.2× 55 0.4× 31 0.4× 35 0.5× 25 325
Aikaterini Stylianaki Greece 13 184 0.4× 200 0.9× 124 0.8× 8 0.1× 8 0.1× 21 580

Countries citing papers authored by Evangelos Sepsas

Since Specialization
Citations

This map shows the geographic impact of Evangelos Sepsas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evangelos Sepsas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evangelos Sepsas more than expected).

Fields of papers citing papers by Evangelos Sepsas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evangelos Sepsas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evangelos Sepsas. The network helps show where Evangelos Sepsas may publish in the future.

Co-authorship network of co-authors of Evangelos Sepsas

This figure shows the co-authorship network connecting the top 25 collaborators of Evangelos Sepsas. A scholar is included among the top collaborators of Evangelos Sepsas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evangelos Sepsas. Evangelos Sepsas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Angelidis, Ilias, Katerina Goudevenou, Alejandro Prados, et al.. (2021). Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts. The Journal of Experimental Medicine. 219(2). 124 indexed citations
2.
Toufektzian, Levon, et al.. (2015). Does postoperative mechanical ventilation predispose to bronchopleural fistula formation in patients undergoing pneumonectomy?: Table 1:. Interactive Cardiovascular and Thoracic Surgery. 21(3). 379–382. 11 indexed citations
3.
Sepsas, Evangelos, et al.. (2013). The role of intercostal cryoanalgesia in post-thoracotomy analgesia. Interactive Cardiovascular and Thoracic Surgery. 16(6). 814–818. 34 indexed citations
4.
Toufektzian, Levon, et al.. (2013). Pleural lavage cytology: Where do we stand?. Lung Cancer. 83(1). 14–22. 12 indexed citations
5.
Sepsas, Evangelos, et al.. (2010). Primitive Neuroectodermal Tumor of the Thoracic Wall in a 48-Year-Old Man. Asian Cardiovascular and Thoracic Annals. 18(3). 285–287. 4 indexed citations
6.
Misthos, Panagiotis, et al.. (2009). Prognosis of stage pIIIA non small cell lung cancer after mediastinal lymph node dissection or sampling.. PubMed. 14(1). 45–9. 2 indexed citations
7.
Misthos, Panagiotis, et al.. (2008). The Significance of One-Station N2 Disease in the Prognosis of Patients With Nonsmall-Cell Lung Cancer. The Annals of Thoracic Surgery. 86(5). 1626–1630. 56 indexed citations
8.
Misthos, Panagiotis, Stamatis Kakaris, Evangelos Sepsas, Kalliopi Athanassiadi, & Ioannis Skottis. (2006). Surgical Management of Late Postpneumonectomy Bronchopleural Fistula: The Transsternal, Transpericardial Route. Respiration. 73(4). 525–528. 9 indexed citations
9.
Sepsas, Evangelos, et al.. (2006). Empyema in the critical care patient. Critical Care. 10(Suppl 1). P138–P138. 1 indexed citations
10.
Misthos, Panagiotis, et al.. (2006). Asymptomatic Solitary Mediastinal Cystic Lymphangioma: A Rare Entity. Asian Cardiovascular and Thoracic Annals. 14(6). 476–478. 8 indexed citations
11.
Misthos, Panagiotis, Stylianos Katsaragakis, Stamatis Kakaris, et al.. (2005). Postresectional pulmonary oxidative stress in lung cancer patients. The role of one-lung ventilation. European Journal of Cardio-Thoracic Surgery. 27(3). 379–383. 129 indexed citations
12.
Misthos, Panagiotis, et al.. (2005). Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study. European Journal of Cardio-Thoracic Surgery. 28(4). 599–603. 92 indexed citations
13.
Athanassiadi, Kalliopi, et al.. (2004). Late Postpneumonectomy Bronchopleural Fistula. The Thoracic and Cardiovascular Surgeon. 52(5). 298–301. 4 indexed citations
14.
Misthos, Panagiotis, Stamatis Kakaris, Evangelos Sepsas, Kalliopi Athanassiadi, & Ioannis Skottis. (2004). A prospective analysis of occult pneumothorax, delayed pneumothorax and delayed hemothorax after minor blunt thoracic trauma☆. European Journal of Cardio-Thoracic Surgery. 25(5). 859–864. 71 indexed citations
15.
Misthos, Panagiotis, Evangelos Sepsas, Kalliopi Athanassiadi, Stamatis Kakaris, & Ioannis Skottis. (2004). Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer. European Journal of Cardio-Thoracic Surgery. 25(4). 502–508. 59 indexed citations
16.
Kosmas, Christos, Νicolas Tsavaris, Thomas Makatsoris, et al.. (2001). A phase I‐II study of docetaxel‐ifosfamide‐cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer. International Journal of Cancer. 98(1). 141–147. 12 indexed citations
17.
Kosmas, Christos, Νicolas Tsavaris, Aristidis Polyzos, et al.. (2000). A Phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma. Cancer. 89(4). 774–782. 21 indexed citations
18.
Alkattan, Khaled, Evangelos Sepsas, E. Townsend, & Samantha Fountain. (1996). Factors affecting long term survival following resection for lung cancer.. Thorax. 51(12). 1266–1269. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026